Connor, Clark & Lunn Investment Management (CC&L)
ALDX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Aldeyra Therapeutics ALDX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
+154,292
New +$265K ﹤0.01% 1478
2026
Q1 		– Sell
-23,858
Closed -$124K – 1536
2025
Q4 		$124K Buy
+23,858
New +$123K ﹤0.01% 1474
2023
Q3 		– Sell
-169,306
Closed -$1.42M – 1345
2023
Q2 		$1.42M Sell
169,306
-13,764
-8% -$136K 0.01% 692
2023
Q1 		$1.82M Sell
183,070
-1,824
-1% -$12.9K 0.01% 576
2022
Q4 		$1.29M Sell
184,894
-41,303
-18% -$236K 0.01% 649
2022
Q3 		$1.21M Buy
226,197
+158,283
+233% +$950K 0.01% 608
2022
Q2 		$271K Buy
+67,914
New +$234K ﹤0.01% 882
2020
Q3 		– Sell
-16,346
Closed -$68K – 917
2020
Q2 		$68K Sell
16,346
-83,376
-84% -$305K ﹤0.01% 973
2020
Q1 		$246K Buy
99,722
+10,225
+11% +$46K ﹤0.01% 833
2019
Q4 		$520K Buy
89,497
+12,325
+16% +$71.2K ﹤0.01% 656
2019
Q3 		$407K Sell
77,172
-18,687
-19% -$101K ﹤0.01% 729
2019
Q2 		$575K Buy
95,859
+13,775
+17% +$104K ﹤0.01% 691
2019
Q1 		$741K Buy
82,084
+34,904
+74% +$297K ﹤0.01% 592
2018
Q4 		$392K Buy
+47,180
New +$483K ﹤0.01% 751

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ALDX Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 154,292 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #1478 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in ALDX as recently as Q4 2025.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ALDX in Q4 2018 and has held it in 14 quarters since. The position peaked at $1.82M in Q1 2023. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 154,292 shares of Aldeyra Therapeutics worth $329K as of Q2 2026.
  • Aldeyra Therapeutics was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1478 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Aldeyra Therapeutics in Q4 2018 and has held it in 14 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Aldeyra Therapeutics position peaked at $1.82M in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.